The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England

BACKGROUND: Parkinson’s disease is a progressive neurodegenerative disease, which significantly impacts patients’ quality of life and is associated with high treatment and direct healthcare costs. In England, levodopa/carbidopa intestinal gel (LCIG) is indicated for the treatment of levodopa-respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhuri, K. Ray, Pickard, A. Simon, Alobaidi, Ali, Jalundhwala, Yash J., Kandukuri, Prasanna L., Bao, Yanjun, Sus, Julia, Jones, Glynn, Ridley, Christian, Oddsdottir, Julia, Najle-Rahim, Seyavash, Madin-Warburton, Matthew, Xu, Weiwei, Schrag, Anette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095547/
https://www.ncbi.nlm.nih.gov/pubmed/35307793
http://dx.doi.org/10.1007/s40273-022-01132-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095547/
https://www.ncbi.nlm.nih.gov/pubmed/35307793
http://dx.doi.org/10.1007/s40273-022-01132-y

Ejemplares similares